openPR Logo
Press release

Investigation announced for Investors who lost money with shares of Cibus, Inc. (NASDAQ: CBUS)

06-25-2024 11:30 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation for investors in Cibus, Inc. (NASDAQ: CBUS) shares over potential securities laws violations by Cibus, Inc.

An investigation for investors in Cibus, Inc. (NASDAQ: CBUS) shares over potential securities laws violations by Cibus, Inc.

An investigation was announced on behalf of investors of Cibus, Inc. (NASDAQ: CBUS) shares over potential securities laws violations by Cibus, Inc.

Investors who purchased shares of Cibus, Inc. (NASDAQ: CBUS), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Cibus, Inc. (NASDAQ: CBUS) concerning whether a series of statements by Cibus, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

San Diego, CA based Cibus, Inc., a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties.

On June 4, 2024, Bonitas Research issued a short report and raised significant concerns regarding Cibus, Inc. and its operations, alleging that insiders benefited from inflated stock valuations post-reverse merger in 2023, thereby necessitating a thorough investigation into the discrepancy between the actual value of intangible assets and the stock prices paid to insiders.

Shares of Cibus, Inc. (NASDAQ: CBUS) declined from $23.18 per share on March 26, 2024, to as low as $8.90 per share on June 25, 2024.

Those who purchased shares of Cibus, Inc. (NASDAQ: CBUS) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Investors who lost money with shares of Cibus, Inc. (NASDAQ: CBUS) here

News-ID: 3553622 • Views:

More Releases from Shareholders Foundation

ALERT: Lawsuit filed for Investors who SOLD shares of Sina Corporation (formerly NASDAQ: SINA)
ALERT: Lawsuit filed for Investors who SOLD shares of Sina Corporation (formerly …
An investor, who sold shares of Sina Corporation (formerly NASDAQ: SINA) in the merger between Seina Corporation and TuSimple Holdings, Inc, filed a lawsuit over alleged violations of Federal Securities Laws by Sina Corporation (formerly NASDAQ: SINA in connection with certain allegedly false and misleading statements made. If you sold a significant amount of shares of Sina Corporation (formerly NASDAQ: SINA) between October 13, 2020 and March 22, 2021, you have
Lawsuit Alert: Investors who lost money with shares of Fluor Corporation (NYSE: FLR) should contact the Shareholders Foundation
Lawsuit Alert: Investors who lost money with shares of Fluor Corporation (NYSE: …
An investor, who purchased shares of Fluor Corporation (NYSE: FLR), filed a lawsuit alleged violations of Federal Securities Laws by Fluor Corporation in connection with certain allegedly false and misleading statements. Investors who purchased shares of Fluor Corporation (NYSE: FLR) have certain options and for certain investors are short and strict deadlines running. Deadline: November 14, 2025. NYSE: FLR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779
Investigation announced for Long-Term Investors in shares of Sable Offshore Corp. (NYSE: SOC)
Investigation announced for Long-Term Investors in shares of Sable Offshore Corp …
An investigation was announced for long-term investors in shares of Sable Offshore Corp. (NYSE: SOC) concerning potential breaches of fiduciary duties by certain directors of Sable Offshore Corp. Investors who are current long term investors in Sable Offshore Corp. (NYSE: SOC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in
Lawsuit filed for Investors who lost money with shares of Lantheus Holdings, Inc. (NASDAQ: LNTH)
Lawsuit filed for Investors who lost money with shares of Lantheus Holdings, Inc …
An investor, who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH), filed a lawsuit over alleged violations of Federal Securities Laws by Lantheus Holdings, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) have certain options and for certain investors are short and strict deadlines running. Deadline: November 10, 2025. NASDAQ: LNTH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com

All 5 Releases


More Releases for Cibus

RNAi Pesticides Market Key Players Analysis - Bayer, Cibus, DuPont, RNAiSSANCE A …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "RNAi Pesticides Market"-, By Application (Insect Pest Control, Weed Management, Disease Management, Resistance Management), By Crop Type (Agricultural Application, Non-Agricultural Application), By Product (Tropical RNAi Pesticide, Seed Embedded RANi, Transgenic RNAi, Others), By Formulation (Liquid Formulation, Granular Formulation, Powder Formulation, Others), Industry Trends, and Global Forecasts, 2024-2031 And Segment Revenue and Forecast To 2034." The RNAi
Bioengineered Foods Market Is Booming So Rapidly | Major Giants Monsanto,Calyxt, …
HTF MI just released the Global Bioengineered Foods Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2032. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach. Major companies profiled in Bioengineered Foods Market are: Bayer CropScience, Syngenta,
RNAi Pesticides Market Top Players - Bayer, Cibus, DuPont, RNAiSSANCE AG, Syngen …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "RNAi Pesticides Market"-, By Application (Insect Pest Control, Weed Management, Disease Management, Resistance Management), By Crop Type (Agricultural Application, Non-Agricultural Application), By Product (Tropical RNAi Pesticide, Seed Embedded RANi, Transgenic RNAi, Others), By Formulation (Liquid Formulation, Granular Formulation, Powder Formulation, Others), Industry Trends, and Global Forecasts, 2024-2031 And Segment Revenue and Forecast To 2031." The RNAi
Recombinant DNA (rDNA) Technology Market | Amgen Inc, Biocon, Cibus, Eli Lilly a …
The global recombinant dna (rdna) technology market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the recombinant dna (rdna) technology market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants. From the perspective of market dynamics, this report explores the factors driving
Global Recombinant DNA technology Market || KEYPLAYERS Pfizer, Inc., F.Hoffmann- …
Growing technological advancement in the genetic engineering field to deliver highly efficient therapeutics for life threatening human diseases and in agriculture field is major driving factor for growth of the global recombinant DNA technology market. In addition, huge expansion of biopharmaceutical industry, coupled with rising research initiatives in this field are major factors expected to foster the target market growth. Also, increasing strategic collaborations among the major players operating in
Export Global Opportunities at Cibus, International Food Exhibition in Parma
Total success for Cibus 2016 International Food Exhibition, the key event of the Italian agri-food sector organised by Fiere di Parma and Federalimentare, a true platform enabling the companies committed to “Made in Italy” food to meet the major distributors, importers and professional of domestic and foreign markets, with three thousand exhibitors spread over 130 thousand square metres and 72 thousand visitors, of whom 16 thousand were foreign